These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. Fruzzetti F, de Lorenzo D, Parrini D, Ricci C. J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369 [Abstract] [Full Text] [Related]
9. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen. Schwartz JI, Tanaka WK, Wang DZ, Ebel DL, Geissler LA, Dallob A, Hafkin B, Gertz BJ. J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518 [Abstract] [Full Text] [Related]
10. Caspase-1 level is higher in the scalp in androgenetic alopecia. de Rivero Vaccari JP, Sawaya ME, Brand F, Nusbaum BP, Bauman AJ, Bramlett HM, Dietrich WD, Keane RW. Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322 [Abstract] [Full Text] [Related]
11. Comparison of finasteride (Proscar) and Serenoa repens (Permixon) in the inhibition of 5-alpha reductase in healthy male volunteers. Strauch G, Perles P, Vergult G, Gabriel M, Gibelin B, Cummings S, Malbecq W, Malice MP. Eur Urol; 1994 Jul; 26(3):247-52. PubMed ID: 7805711 [Abstract] [Full Text] [Related]
12. Value of hormonal levels in patients with male androgenetic alopecia treated with finasteride: better response in patients under 26 years old. Camacho FM, García-Hernández MJ, Fernández-Crehuet JL. Br J Dermatol; 2008 May; 158(5):1121-4. PubMed ID: 18363752 [Abstract] [Full Text] [Related]
14. Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ. J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):578-89. PubMed ID: 9777765 [Abstract] [Full Text] [Related]
17. Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia. Price VH, Roberts JL, Hordinsky M, Olsen EA, Savin R, Bergfeld W, Fiedler V, Lucky A, Whiting DA, Pappas F, Culbertson J, Kotey P, Meehan A, Waldstreicher J. J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):768-76. PubMed ID: 11050579 [Abstract] [Full Text] [Related]
19. Effect of MK-386, a novel inhibitor of type 1 5 alpha-reductase, alone and in combination with finasteride, on serum dihydrotestosterone concentrations in men. Schwartz JI, Van Hecken A, De Schepper PJ, De Lepeleire I, Lasseter KC, Shamblen EC, Winchell GA, Constanzer ML, Chavez CM, Wang DZ, Ebel DL, Justice SJ, Gertz BJ. J Clin Endocrinol Metab; 1996 Aug; 81(8):2942-7. PubMed ID: 8768856 [Abstract] [Full Text] [Related]